Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
738.50    -6.00 (-0.81%)
Bid:
736.00
Ask:
739.50
Spread: 3.50 (0.476%)
Market Cap: £2.48b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Director/PDMR Shareholding

27 May 2020 14:30

RNS Number : 1122O
Drax Group PLC
27 May 2020
 

27 May 2020

DRAX GROUP PLC

Symbol: DRX

 

Notification of Transactions of Directors,

Persons Discharging Managerial Responsibility or Connected Persons

 

The notifications below are all in accordance with the requirements of Article 19 (3) of the EU Market Abuse Regulation 596/2014 and the dealings were in respect of ordinary shares of 11 16/29 pence each in the share capital of Drax Group plc (the "Company").

 

Following the appointment of Mike Maudsley to the Executive Committee of the Company, an award has been granted to him under the Drax Group plc Long Term Incentive Plan 2020 ("LTIP").

 

On 27 May 2020, an award over 97,465 shares was made under the LTIP to Mike Maudsley. The performance award, made for nil consideration, is a conditional award with vesting normally deferred for three years, subject to the satisfaction of certain performance conditions and to the participant remaining in employment until the vesting date.

 

The award is made under the same terms and with the same performance conditions as the awards made to members of the Executive Committee on 7th May 2020. There may arise circumstances during the Vesting Period where adjustment or discretion is applied by the Remuneration Committee by reference to exceptional items and the Directors' Remuneration Policy. The application of such adjustments would be considered during and upon completion of the Vesting Period. In making their assessment, the Remuneration Committee will take into account appropriate advice (for example from the Company's auditors, the Remuneration Committee advisers or the Audit Committee), also giving due consideration to the shareholder experience and to what extent the outcome incorporates any windfall gain, which warrants adjustment. The Remuneration Committee would also take into account exceptional and unforeseen circumstances in assessing the appropriate level of Vesting judged against the performance of the Company and management at the end of the Vesting Period.

 

There were 410,755,481 shares in issue at the time of this notification.

 

The information below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Mike Maudsley

2.

Reason for the notification

a)

Position / status

UK Portfolio Generation Director

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Drax Group plc

b)

LEI

549300YPSNTXR4ZHSR98

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 11 16/29 pence

GB00BIVNSX38

b)

Nature of the transaction

Award made pursuant to the Drax Group plc Long Term Incentive Plan 2020 ("LTIP")

c)

Price(s) and volume(s)

Price(s)

Volume(s)

nil

97,465

  

d)

Aggregated information

- Aggregated volume

- Price

 

N/A

e)

Date of the transaction

 27 May 2020

f)

Place of the transaction

Outside a trading venue

 

 

 

 

 

--ENDS--

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHARMTTMTATBPM
Date   Source Headline
25th Mar 20248:45 amRNSAdditional Listing
22nd Mar 202410:54 amRNSHolding(s) in Company
21st Mar 20248:00 amRNSMailing of Annual Report and Notice of AGM
18th Mar 20242:04 pmRNSHolding(s) in Company
18th Mar 202410:30 amRNSDirector/PDMR Shareholding
15th Mar 20242:51 pmRNSHolding(s) in Company
14th Mar 20241:37 pmRNSHolding(s) in Company
11th Mar 202412:26 pmRNSHolding(s) in Company
8th Mar 20244:07 pmRNSHolding(s) in Company
6th Mar 20242:46 pmRNSHolding(s) in Company
4th Mar 20243:35 pmRNSTotal Voting Rights
4th Mar 20243:18 pmRNSHolding(s) in Company
1st Mar 20242:38 pmRNSHolding(s) in Company
29th Feb 20247:04 amRNSNon-Executive Director standing down
29th Feb 20247:00 amRNSAnnual Financial Report
28th Feb 20247:00 amRNSCapacity Market Agreements
27th Feb 20249:20 amRNSHolding(s) in Company
23rd Feb 20244:32 pmRNSHolding(s) in Company
22nd Feb 202412:46 pmRNSNotice of Results
21st Feb 20249:32 amRNSHolding(s) in Company
15th Feb 202410:51 amRNSHolding(s) in Company
13th Feb 202412:47 pmRNSHolding(s) in Company
7th Feb 202410:32 amRNSHolding(s) in Company
1st Feb 202411:56 amRNSTotal Voting Rights
31st Jan 20243:16 pmRNSHolding(s) in Company
30th Jan 20242:15 pmRNSHolding(s) in Company
30th Jan 20248:45 amRNSAdditional Listing
29th Jan 20243:02 pmRNSHolding(s) in Company
25th Jan 20249:37 amRNSHolding(s) in Company
23rd Jan 20243:43 pmRNSHolding(s) in Company
18th Jan 202411:54 amRNSBridging Mechanism Consultation
16th Jan 20249:25 amRNSHolding(s) in Company
12th Jan 20243:29 pmRNSHolding(s) in Company
10th Jan 20241:22 pmRNSHolding(s) in Company
2nd Jan 202412:50 pmRNSTotal Voting Rights
27th Dec 20234:59 pmRNSHolding(s) in Company
20th Dec 20231:13 pmRNSDevelopment of UK CCS and BECCS business model
18th Dec 20238:45 amRNSAdditional Listing
5th Dec 20234:10 pmRNSTotal Voting Rights
5th Dec 20237:00 amRNSTrading Update
30th Nov 202311:03 amRNSHolding(s) in Company
29th Nov 20233:28 pmRNSHolding(s) in Company
27th Nov 20234:32 pmRNSHolding(s) in Company
13th Nov 202312:10 pmRNSHolding(s) in Company
8th Nov 20234:17 pmRNSHolding(s) in Company
2nd Nov 202311:42 amRNSHolding(s) in Company
1st Nov 20239:42 amRNSTotal Voting Rights
30th Oct 20238:30 amRNSDirector/PDMR Shareholding
27th Oct 20232:21 pmRNSHolding(s) in Company
24th Oct 20234:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.